Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study.
Saved in:
| Title: | Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study. |
|---|---|
| Authors: | Solovyeva O; The Institute of Cancer Research, London, UK., Dimairo M; Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK., Weir CJ; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK., Hee SW; University Hospitals Coventry & Warwickshire NHS Trust, Coventry, UK.; University of Warwick, Coventry, UK., Espinasse A; The Institute of Cancer Research, London, UK., Ursino M; Inserm, Centre de Recherche Des Cordeliers, Sorbonne UniversitéUniversité Paris Cité, 75006, Paris, France.; HeKA, Inria Paris, 75015, Paris, France.; Unit of Clinical Epidemiology, AP-HP, CHU Robert Debré, CIC-EC 1426, Paris, France.; RECaP/F-CRIN, Inserm, 5400, Nancy, France., Patel D; The Institute of Cancer Research, London, UK., Kightley A; Patient and Public Involvement and Engagement (PPIE) Lead, Lichfield, UK., Hughes S; University of Birmingham, Birmingham, UK., Jaki T; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.; University of Regensburg, Regensburg, Germany., Mander A; GSK, Brentford, UK., Evans TRJ; University of Glasgow, Glasgow, UK., Lee S; Columbia University, Mailman School of Public Health, New York, USA., Hopewell S; Oxford Clinical Trials Research Unit, University of Oxford, Oxford, UK., Rantell KR; Medicines and Healthcare Products Regulatory Agency, London, UK., Chan AW; Department of Medicine, Women's College Research Institute, University of Toronto, Toronto, Canada., Bedding A; Roche Products Ltd, Welwyn Garden City, UK., Stephens R; NCRI, London, UK., Richards D; Clinical Trials Ontario, Toronto, Canada., Roberts L; NCRI, London, UK., Kirkpatrick J; Roche Products Ltd, Welwyn Garden City, UK., de Bono J; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Yap C; The Institute of Cancer Research, London, UK. Christina.yap@icr.ac.uk. |
| Source: | BMC medicine [BMC Med] 2023 Jul 05; Vol. 21 (1), pp. 246. Date of Electronic Publication: 2023 Jul 05. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1741-7015 |
|---|---|
| DOI: | 10.1186/s12916-023-02937-0 |
